Equities

iSpecimen Inc

ISPC:NAQ

iSpecimen Inc

Actions
Health CareHealth Care Providers
  • Price (USD)0.263
  • Today's Change-0.004 / -1.31%
  • Shares traded313.00
  • 1 Year change-84.89%
  • Beta--
Data delayed at least 15 minutes, as of May 03 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

iSpecimen Inc. is a technology-driven company. The Company's iSpecimen Marketplace platform is designed to transform the biospecimen procurement process to accelerate medical discovery. The Company's technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. Its iSpecimen Marketplace platform has compiled de-identified healthcare data provided by its healthcare supply partners. The platform is built upon a robust healthcare data set comprised of information about available specimens and research subjects. The Company’s platform helps with administrative and reporting functions for researchers, suppliers, and its internal personnel, including user and compliance management. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data, administrative, compliance and reporting.

  • Revenue in USD (TTM)9.93m
  • Net income in USD-11.10m
  • Incorporated2009
  • Employees53.00
  • Location
    iSpecimen Inc450 Bedford St Ste 1010LEXINGTON 02420-1535United StatesUSA
  • Phone+1 (781) 301-6700
  • Fax+1 (302) 655-5049
  • Websitehttp://www.ispecimen.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Vizconnect Inc7.96k-224.96m1.84m1.00------231.21-191.47-191.470.0153-157.080.5247-------1,482,895.00-----------2,826,069.00-----0.0043--------2.25------
iEntertainment Network Inc1.30m-1.76m1.91m18.00------1.47-0.0638-0.06070.0399-0.00230.9478--7.8372,166.66-123.90-123.52-516.90-306.8661.3561.12-130.72-95.07---246.20-----76.50-23.1566.41---13.22--
APPlife Digital Solutions Inc21.64k-3.10m1.96m1.00------90.79-0.0548-0.05480.0004-0.01110.09640.5541--21,640.00-1,379.92-907.64-----60.12---14,319.50-20,132.380.1103-4.17----66.48--1.26------
Xalles Holdings Inc416.69k-180.79k2.09m7.00------5.02-0.0002-0.00020.0004-0.00110.4184----59,527.14-18.15-----------43.39-----209.332.02---49.04---155.59------
Infrax Systems Inc0.00-39.27k2.21m7.00---------0.00004-0.000040.00-0.000080.000.00-----5.17-44.99-14.42-135.59--80.37---1,435.400.0001-6.701.26-------108.72------
Perpetual Industries Inc8.35m-459.50k2.28m2.00--0.2525.860.2731-0.0059-0.00590.10790.10920.857295.69596.03---4.72---6.92--45.20---5.50--0.7257-4.660.0937------85.92------
iSpecimen Inc9.93m-11.10m2.39m53.00--0.2452--0.2407-1.23-1.231.101.070.491--2.89187,324.20-54.90-49.18-73.73-145.1651.4553.26-111.80-90.30----0.00---4.5617.70-8.33--35.84--
Leafbuyer Technologies Inc5.22m-957.96k2.41m14.00------0.4621-0.0097-0.00970.053-0.01733.24--51.22372,680.00-59.51-62.47----35.7633.53-18.36-62.40---6.16----33.7235.17-161.23------
1606 Corp1.60k-1.58m2.55m2.00------1,593.06-0.0341-0.03410.00003-0.02420.00840.0108--800.00-831.61------37.50---98,795.63--0.1232-------88.52---192.71------
Borqs Technologies Inc52.54m-24.12m2.68m315.00------0.0509-11.69-16.0627.47-2.271.267.2518.29166,784.10-69.42-70.26----21.162.93-55.09-66.110.62620.0085----77.72-15.5456.83---38.99--
Voice Assist Inc327.69k-2.79m2.71m15.00------8.27-0.0645-0.06450.0076-0.03350.504--4.7520,480.63-429.12-------17.49---851.37-----36.89-----35.25--70.09------
Raadr Inc0.00-2.74m2.77m1.00---------18,955.22-18,955.220.00-3,536.270.00----0.00-172,517.00-----------------0.7905--------35.23------
Avenir Wellness Solutions Inc4.14m-10.56m2.85m14.00------0.6899-0.1476-0.14760.0578-0.13620.46533.5613.68295,571.40-118.80-73.99---158.5463.0062.33-255.29-667.090.1373-182.16-----24.7195.67-40.53------
Data as of May 03 2024. Currency figures normalised to iSpecimen Inc's reporting currency: US Dollar USD

Institutional shareholders

4.16%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Dec 2023134.10k1.48%
BlackRock Fund Advisorsas of 31 Dec 202356.70k0.62%
Citadel Securities LLCas of 31 Dec 202338.81k0.43%
Geode Capital Management LLCas of 31 Dec 202338.50k0.42%
Grimes & Co., Inc.as of 31 Mar 202430.82k0.34%
Millennium Management LLCas of 31 Dec 202321.49k0.24%
Schonfeld Strategic Advisors LLCas of 31 Dec 202317.50k0.19%
Osaic Wealth, Inc. (Investment Management)as of 31 Dec 202315.52k0.17%
Northern Trust Investments, Inc.(Investment Management)as of 31 Dec 202313.81k0.15%
Renaissance Technologies LLCas of 31 Dec 202310.69k0.12%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.